G1 phase cell cycle arrest in NSCLC in response to LZ-106, an analog of enoxacin, is orchestrated through ROS overproduction in a P53-dependent manner-Reference-Cited by-同舟云学术

G1 phase cell cycle arrest in NSCLC in response to LZ-106, an analog of enoxacin, is orchestrated through ROS overproduction in a P53-dependent manner

Published:2018-09-15 Issue:1 Volume:40 Page:131-144
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:

Author:

Yang Lin¹,Zhou Jieying¹,Meng Fei²,Fu Chengyu¹,Zou Xiaoqian¹,Liu Jinfeng¹,Zhang Chengwan³,Tan Renxiang⁴,Li Zhiyu⁵,Guo Qinglong¹^ORCID,Wei Libin¹

Affiliation:

1. State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Tongjiaxiang, Nanjing, China

2. Department of Clinical Laboratory, Jiangsu Province Hospital of Traditional Chinese Medicine, Nanjing, China

3. The Central Laboratory of Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, Jiangsu Province, China

4. State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine, Nanjing, China

5. Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Tongjiaxiang, Nanjing, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

National Science and Technology Major Project

Special Foundation for Jiangsu Overseas Visiting Scholar Program of Prominent Young Teachers and Presidents

program for construction of innovation ability in Huai’an

Open Project of State Key Laboratory Cultivation Base for TCM Quality and Efficacy

Nanjing University of Chinese Medicine

Program for Changjiang Scholars and Innovative Research Team in University

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/40/1/131/28044576/bgy124.pdf

Reference50 articles.

1. Cancer statistics in China, 2015;Chen;CA. Cancer J. Clin,2016

2. Cancer statistics, 2017;Siegel;CA. Cancer J. Clin,2017

3. NCCN guidelines insights: non-small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines;Ettinger;J. Natl. Compr. Canc. Netw,2018

4. Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data [published erratum appears in Lancet Oncol. 2008 May;9(5):416];Verdecchia;Lancet Oncol,2007

5. p53 in survival, death and metabolic health: a lifeguard with a licence to kill;Kruiswijk;Nat. Rev. Mol. Cell Biol,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PSME3 promotes lung adenocarcinoma development by regulating the TGF-β/SMAD signaling pathway;Translational Lung Cancer Research;2024-06

2. Topoisomerase II inhibitors design: Early studies and new perspectives;Bioorganic Chemistry;2023-07

3. RBM39 is a potential prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma;2023-04-12

4. The New Face of a Well-Known Antibiotic: A Review of the Anticancer Activity of Enoxacin and Its Derivatives;Cancers;2022-06-22

5. Anti-tumor effects of an ID antagonist with no observed acquired resistance;npj Breast Cancer;2021-05-24